Checking UNCY unusual options activity helps you spot when traders are making outsized bets on Unicycive Therapeutics Inc before the broader market catches on. Unicycive Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor UNCY unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching UNCY unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking UNCY unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and UNCY unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Catalysts rarely arrive without a footprint, and UNCY unusual options activity is often where that footprint shows up first. Our scanner tracks Unicycive Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at UNCY unusual options volume on the call side or chasing put sweeps, Unicycive Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
